Fujian Haixi Pharmaceuticals Co Ltd Sustainability Reports
The company is a commercial-stage innovative pharmaceutical company that integrates the R&D, clinical research, manufacturing, and commercialization of generic and innovative drugs. Its therapeutic focus includes digestive, cardiovascular, oncology, ophthalmology, endocrine, and nervous system diseases.
Sector: Manufacturing
Country: China
Exchange: Hong Kong Stock Exchange
FIGI: BBG01XT0YD35
1 reports from 2025 to 2025
